WallFlex™ Biliary M00570620Recalls & reported problems
Boston Scientific Corporation · Stent System · Class 2 · Implant
All models of WallFlex Biliary (23)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08714729759263), received between Jun 7, 2017 and Dec 4, 2020 — classified as 1 injury, 4 malfunctions.
The most frequently reported specific device problem is “Entrapment of Device” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Entrapment of Device2
- Premature Activation2
- Break1
- Difficult to Advance1
- Material Deformation1
- Problem with Sterilization1
Patient problems
- No Consequences Or Impact To Patient5
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 4, 2020Entrapment of Device; Premature Activation; Difficult to Advance; Entrapment of Device; Premature Activation; Difficult to Advance
NOTE: THIS REPORT PERTAINS TO ONE OF TWO PROCEDURES INVOLVING ONE WALLFLEX BILIARY STENT. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON NOVEMBER 10, 2020 THAT A WALLFLEX BILIARY RX UNCOVERED STENT WAS TO BE IMPLANTED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2020. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, RESISTANCE WAS ENCOUNTERED WHILE ADVANCING THE DELIVERY SYSTEM THROUGH THE SCOPE. THE DEVICE WAS REMOVED FROM THE SCOPE AND ANOTHER WALLFLEX BILIARY UNCOVERED STENT WAS IMPLANTED TO COMPLETE THE PROCEDURE. REPORTEDLY, LATER THAT DAY, THE SAME NON BOSTON SCIENTIFIC SCOPE WAS REPROCESSED AND WAS USED IN A DIFFERENT PROCEDURE. DURING THE PROCEDURE, A SNARE WAS ADVANCED THROUGH THE SCOPE BUT RESISTANCE WAS ENCOUNTERED AND NOTED A DEPLOYED WALLFLEX BILIARY STENT FROM THE PREVIOUS PROCEDURE WAS COMING OUT FROM THE DISTAL END OF THE SCOPE. THE PHYSICIAN THEN REMOVED THE SCOPE AND PULLED THE STENT OUT OF THE SCOPE. REPORTEDLY, THE PREVIOUSLY ADVANCED WALLFLEX BILIARY RX UNCOVERED STENT WAS PREMATURELY DEPLOYED FROM THE CATHETER INSIDE THE SCOPE DURING REMOVAL AND REMAINED IN TH
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10943382 ↗MalfunctionDec 4, 2020Entrapment of Device; Problem with Sterilization; Entrapment of Device; Problem with Sterilization
NOTE: THIS REPORT PERTAINS TO ONE OF TWO PROCEDURES INVOLVING ONE WALLFLEX BILIARY STENT. IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON NOVEMBER 10, 2020 THAT A WALLFLEX BILIARY RX UNCOVERED STENT WAS TO BE IMPLANTED IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2020. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, RESISTANCE WAS ENCOUNTERED WHILE ADVANCING THE DELIVERY SYSTEM THROUGH THE SCOPE. THE DEVICE WAS REMOVED FROM THE SCOPE AND ANOTHER WALLFLEX BILIARY UNCOVERED STENT WAS IMPLANTED TO COMPLETE THE PROCEDURE. REPORTEDLY, LATER THAT DAY, THE SAME NON BOSTON SCIENTIFIC SCOPE WAS REPROCESSED AND WAS USED IN A DIFFERENT PROCEDURE. DURING THE PROCEDURE, A SNARE WAS ADVANCED THROUGH THE SCOPE BUT RESISTANCE WAS ENCOUNTERED AND NOTED A DEPLOYED WALLFLEX BILIARY STENT FROM THE PREVIOUS PROCEDURE WAS COMING OUT FROM THE DISTAL END OF THE SCOPE. THE PHYSICIAN THEN REMOVED THE SCOPE AND PULLED THE STENT OUT OF THE SCOPE. REPORTEDLY, THE PREVIOUSLY ADVANCED WALLFLEX BILIARY RX UNCOVERED STENT WAS PREMATURELY DEPLOYED FROM THE CATHETER INSIDE THE SCOPE DURING REMOVAL AND REMAINED IN TH
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10943302 ↗MalfunctionJul 21, 2020Material Deformation; Material Deformation
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON (B)(6) 2020 THAT A WALLFLEX BILIARY RX UNCOVERED STENT WAS TO BE USED TO TREAT A BILIARY TRACT TUMOR DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2020. ACCORDING TO THE COMPLAINANT, DURING PREPARATION AFTER THE STENT WAS UNPACKAGED, THE STENT WAS PURPOSEFULLY PREDEPLOYED OUTSIDE THE PATIENT AND IT WAS NOTICED THAT THE DISTAL END OF THE STENT WAS BENT AND DEFORMED. THE PROCEDURE WAS COMPLETED WITH ANOTHER WALLFLEX BILIARY STENT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10303100 ↗InjuryFeb 14, 2019Premature Activation; Premature Activation
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON JANUARY 21, 2019 THAT A WALLFLEX BILIARY RX UNCOVERED STENT WAS TO BE USED TO TREAT A MALIGNANT STRICTURE IN THE COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2019. REPORTEDLY, THE PATIENT'S ANATOMY WAS NOT TORTUOUS AND WAS NOT DILATED PRIOR TO STENT PLACEMENT. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, THE STENT WAS PREMATURELY DEPLOYED INSIDE THE PATIENT. THE STENT WAS REMOVED WITH FORCEPS AND ANOTHER WALLFLEX BILIARY STENT WAS PLACED TO COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8339239 ↗MalfunctionJun 7, 2017Break; Break
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A WALLFLEX BILIARY RX UNCOVERED STENT WAS TO BE USED TO TREAT A MALIGNANT STRICTURE IN THE PROXIMAL COMMON BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) WITH STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2017. REPORTEDLY, THE PATIENT'S ANATOMY WAS NOT TORTUOUS AND WAS NOT DILATED PRIOR TO STENT PLACEMENT. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, THE STENT FAILED TO DEPLOY. THE PROCEDURE WAS COMPLETED WITH ANOTHER WALLFLEX BILIARY RX STENT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE FINE. NOTE: THIS EVENT HAS BEEN DEEMED AN MDR-REPORTABLE EVENT BASED ON INVESTIGATION RESULTS WHICH REVEALED THAT THE PROXIMAL END OF THE GUIDEWIRE ACCESS SLEEVE WAS DETACHED FROM THE OUTER SHEATH.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6618784 ↗
Other CATHETER, BILIARY, DIAGNOSTIC devices
- Hurricane™ RX M00545900Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls1 death705 reports
- MUSTANG™ H74939171060470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC384 reports
- CRE™ PRO M00558710Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC1 recall284 reports
- Hurricane™ RX M00545920Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls211 reports
- MUSTANG™ H74939171070470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC265 reports
- MUSTANG™ H74939171050470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC212 reports
- Hurricane™ RX M00545940Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls109 reports
- MUSTANG™ H74939171100470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC203 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page